The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Developments of PROTACs technology in immune-related diseases.EBI
The Affiliated Hospital of Qingdao University
Pleiotropic effects of a mitochondrion-targeted glutathione reductase inhibitor on restraining tumor cells.EBI
The Affiliated Hospital of Qingdao University
Developments of CRBN-based PROTACs as potential therapeutic agents.EBI
The Affiliated Hospital of Qingdao University
VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives.EBI
The Affiliated Hospital of Qingdao University
Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption.EBI
The Affiliated Hospital of Qingdao University
One-step modification to identify dual-inhibitors targeting both pancreatic triglyceride lipase and Niemann-Pick C1-like 1.EBI
The Affiliated Hospital of Qingdao University
Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease.BDB
Northeast Ohio Medial University